

Regulatory compliance for chemical, cosmetic and biocidal products.
(Published in Official Journal of the European Union, 30.12.2006, L 396, 1–849)
Recitals (p 1) (131)
TABLE OF CONTENTS (p 41)
Chapter 1: Aim, scope and application (p 47)
1 |
Aim and scope |
47 |
2 |
Application |
48 |
Chapter 2: Definitions and general provision (p 53)
3 |
Definitions |
53 |
4 |
General provision |
61 |
Chapter 1: General obligation to register and information requirements (p 62)
5 |
No data, no market |
62 |
6 |
General obligation to register substances on their own or in preparations |
62 |
7 |
Registration and notification of substances in articles |
63 |
8 |
Only representative of a non-Community manufacturer |
66 |
9 |
Exemption from the general obligation to register for PPORD |
67 |
10 |
Information to be submitted for general registration purposes |
70 |
11 |
Joint submission of data by multiple registrants |
72 |
12 |
Information to be submitted depending on tonnage |
73 |
13 |
General requirements for generation of information in intrinsic properties of substances |
75 |
14 |
Chemical safety report and duty to apply and recommend risk reduction measures |
77 |
Chapter 2: Substances regarded as being registered (p 80)
15 |
Substances in plant protection and biocidal products |
80 |
16 |
Duties of the Commission, the Agency and registrants of substances regarded as being registered |
81 |
Chapter 3: Obligation to register and information requirements for certain types of isolated intermediates (p 82)
17 |
Registration of on-site isolated intermediates |
82 |
18 |
Registration of transported isolated intermediates |
83 |
19 |
Joint submission of data on isolated intermediates by multiple registrants |
86 |
Chapter 4: Common provisions for all registrants (p 87)
20 |
Duties of the Agency |
87 |
21 |
Manufacturing and import of substances |
90 |
22 |
Further duties of registrants |
91 |
Chapter 5: Transitional provisions applicable to phase-in substances and notified substances (p 94)
23 |
Specific provisions for phase-in substances |
94 |
24 |
Notified substances |
95 |
Chapter 1: Objectives and general rules (p 96)
25 |
Objectives and general rules |
96 |
Chapter 2: Rules for non-phase-in substances and registrants of phase-in substances who have not pre-registered (p 97)
26 |
Duty to inquire prior to registration |
97 |
27 |
Sharing of existing data in the case of registered substances |
98 |
Chapter 3: Rules for phase-in-substances (p 101)
28 |
Duty to pre-register for phase-in substances |
101 |
29 |
Substance Information Exchange Fora |
104 |
30 |
Sharing of data involving tests |
105 |
31 |
Requirements for safety data sheets |
107 |
32 |
Duty to communicate information down the supply chain for substances on their own or in preparations for which a safety data sheet is not required |
111 |
33 |
Duty to communicate information on substances in articles |
113 |
34 |
Duty to communicate information on substances and preparations up the supply chain |
113 |
35 |
Access to information for workers |
114 |
36 |
Obligation to keep information |
114 |
37 |
Downstream user chemical safety assessments and duty to identify, apply and recommend risk reduction measures |
115 |
38 |
Obligation for downstream users to report information |
119 |
39 |
Application of downstream user obligations |
120 |
Chapter 1: Dossier evaluation (p 121)
40 |
Examination of testing proposals |
121 |
41 |
Compliance check of registrations |
123 |
42 |
Check of information submitted and follow-up to dossier evaluation |
125 |
43 |
Procedure and time periods for examination of testing proposals |
126 |
Chapter 2: Substance evaluation (p 127)
44 |
Criteria for substance evaluation |
127 |
45 |
Competent authority |
128 |
46 |
Requests for further information and check of information submitted |
130 |
47 |
Coherence with other activities |
131 |
48 |
Follow-up to substance evaluation |
132 |
Chapter 3: Evaluation of intermediates (p 132)
49 |
Further information on on-site isolated intermediates |
132 |
Chapter 4: Common provisions (p 133)
50 |
Registrants’ and downstream users’ rights |
133 |
51 |
Adoption of decisions under dossier evaluation |
134 |
52 |
Adoption of decisions under substance evaluation |
136 |
53 |
Cost sharing for tests without an agreement between registrants and/or downstream users |
137 |
Chapter 1: Authorisation requirement (p 138)
55 |
Aim of authorisation and considerations for substitution |
138 |
56 |
General provisions |
139 |
57 |
Substances to be included in Annex XIV |
141 |
58 |
Inclusion of substances in Annex XIV |
143 |
59 |
Identification of substances referred to in Article 57 |
146 |
Chapter 2: Granting of authorisations (p 148)
60 |
Granting of authorisations |
148 |
61 |
Review of authorisations |
152 |
62 |
Applications for authorisations |
155 |
63 |
Subsequent applications for authorisation |
158 |
64 |
Procedure for authorisation decisions |
158 |
Chapter 1: General issues (p 163)
67 |
General provisions |
163 |
Chapter 2: Restrictions process (p 164)
68 |
Introducing new and amending current restrictions |
164 |
69 |
Preparation of a proposal |
165 |
70 |
Agency opinion: Committee for Risk Assessment |
168 |
71 |
Agency opinion: Committee for Socio-economic Analysis |
169 |
72 |
Submission of an opinion to the Commission |
170 |
73 |
Commission decision |
170 |
74 |
Fees and charges |
171 |
75 |
Establishment and review |
173 |
76 |
Composition |
173 |
77 |
Tasks |
175 |
78 |
Powers of the Management Board |
179 |
79 |
Composition of the Management Board |
180 |
80 |
Chairmanship of the Management Board |
181 |
81 |
Meetings of the Management Board |
181 |
82 |
Voting of the Management Board |
182 |
83 |
Duties and powers of the Executive Director |
182 |
84 |
Appointment of the Executive Director |
185 |
85 |
Establishment of the Committees |
186 |
86 |
Establishment of the Forum |
188 |
87 |
Rapporteurs of Committees and use of experts |
190 |
88 |
Qualification and interests |
192 |
89 |
Establishment of the Board of Appeal |
192 |
90 |
Members of the Board of Appeal |
193 |
91 |
Decisions subject to appeal |
195 |
92 |
Persons entitled to appeal, time-limits, fees and form |
195 |
93 |
Examination and decisions on appeal |
196 |
94 |
Actions before the Court of First Instance and the Court of Justice |
196 |
95 |
Conflicts of opinion with other bodies |
197 |
96 |
The budget of the Agency |
198 |
97 |
Implementation of the budget of the Agency |
200 |
98 |
Combating fraud |
201 |
99 |
Financial rules |
202 |
100 |
Legal personality of the Agency |
203 |
101 |
Liability of the Agency |
203 |
102 |
Privileges and immunities of the Agency |
204 |
103 |
Staff rules and regulations |
204 |
104 |
Languages |
205 |
105 |
Duty of confidentiality |
205 |
106 |
Participation of third countries |
205 |
107 |
Participation of international organisations |
206 |
108 |
Contacts with stakeholder organisations |
206 |
109 |
Rules on transparency |
206 |
110 |
Relations with relevant Community bodies |
207 |
111 |
Formats and software for submission of information to the Agency |
208 |
112 |
Scope |
208 |
113 |
Obligation to notify the Agency |
209 |
114 |
Classification and labelling inventory |
211 |
115 |
Harmonisation of classification and labelling |
212 |
116 |
Transitional arrangements |
212 |
117 |
Reporting |
213 |
118 |
Access to information |
214 |
119 |
Electronic public access |
215 |
120 |
Cooperation with third countries and international organisations |
218 |
121 |
Appointment |
219 |
122 |
Cooperation between competent authorities |
219 |
123 |
Communication to the public of information on risks of substances |
220 |
124 |
Other responsibilities |
220 |
125 |
Tasks of the Member States |
221 |
126 |
Penalties for non-compliance |
221 |
127 |
Report |
222 |
128 |
Free movement |
222 |
129 |
Safeguard clause |
223 |
130 |
Statement of reasons for decisions |
224 |
131 |
Amendments to the Annexes |
224 |
132 |
Implementing legislation |
225 |
133 |
Committee procedure |
225 |
134 |
Preparation of establishment of the Agency |
226 |
135 |
Transitional measures regarding notified substances |
226 |
136 |
Transitional measures regarding existing substances |
227 |
137 |
Transitional measures regarding restrictions |
229 |
138 |
Review |
230 |
139 |
Repeals |
233 |
140 |
Amendment of Directive 1999/45/EC |
233 |
141 |
Entry into force and application |
233 |
I |
GENERAL PROVISIONS FOR ASSESSING SUBSTANCES AND PREPARING CHEMICAL SAFETY REPORTS |
237 |
II |
GUIDE TO THE COMPILATION OF SAFETY DATA SHEETS |
267 |
III |
CRITERIA FOR SUBSTANCES REGISTERED IN QUANTITIES BETWEEN 1 AND 10 TONNES |
294 |
IV |
EXEMPTIONS FROM THE OBLIGATION TO REGISTER IN ACCORDANCE WITH ARTICLE 2(7)(a) [MINIMUM RISK] |
295 |
V |
EXEMPTIONS FROM THE OBLIGATION TO REGISTER IN ACCORDANCE WITH ARTICLE 2(7)(b) [REGISTRATION DEEMED UNNECESSARY OR INAPPROPRIATE] |
304 |
VI |
INFORMATION REQUIREMENTS REFERRED TO IN ARTICLE 10 [INFORMATION TO BE SUBMITTED FOR GENERAL REGISTRATION PURPOSES]: GUIDANCE NOTE ON FULFILLING THE REQUIREMENTS OF ANNEXES VI TO XI |
306 |
VII |
STANDARD INFORMATION REQUIREMENTS FOR SUBSTANCES MANUFACTURED OR IMPORTED IN QUANTITIES OF 1 TONNE OR MORE |
316 |
VIII |
STANDARD INFORMATION REQUIREMENTS FOR SUBSTANCES MANUFACTURED OR IMPORTED IN QUANTITIES OF 10 TONNES OR MORE |
330 |
IX |
STANDARD INFORMATION REQUIREMENTS FOR SUBSTANCES MANUFACTURED OR IMPORTED IN QUANTITIES OF 100 TONNE OR MORE |
344 |
X |
STANDARD INFORMATION REQUIREMENTS FOR SUBSTANCES MANUFACTURED OR IMPORTED IN QUANTITIES OF 1000 TONNES OR MORE |
360 |
XI |
GENERAL RULES FOR ADAPTATION OF THE STANDARD TESTING REGIME SET OUT IN ANNEXES VII TO X |
371 |
XII |
GENERAL PROVISIONS FOR DOWNSTREAM USERS TO ASSESS SUBSTANCES AND PREPARE CHEMICAL SAFETY REPORTS |
379 |
XIII |
CRITERIA FOR THE IDENTIFICATION OF PERSISTENT, BIOACCUMULATIVE AND TOXIC SUBSTANCES, AND VERY PERSISTENT AND VERY BIOACCUMULATIVE SUBSTANCES |
383 |
XIV |
LIST OF SUBSTANCES SUBJECT TO AUTHORISATION |
386 |
XV |
DOSSIERS [CMRs, PBTs, vPvBs, etc.] |
387 |
XVI |
SOCIO-ECONOMIC ANALYSIS |
392 |
XVII |
RESTRICTIONS ON THE MANUFACTURE, PLACING ON THE MARKET AND USE OF CERTAIN DANGEROUS SUBSTANCES, PREPARATIONS AND ARTICLES |
395 |
Copyright Alchemy Compliance Disclaimer
FOR MORE INFORMATION PLEASE EMAIL: INFO@ALCHEMYCOMPLIANCE.COM